Sugarloaf Wealth Management LLC Has $279,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sugarloaf Wealth Management LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 568 shares of the medical equipment provider’s stock after purchasing an additional 34 shares during the period. Sugarloaf Wealth Management LLC’s holdings in Intuitive Surgical were worth $279,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Atomi Financial Group Inc. lifted its position in shares of Intuitive Surgical by 15.0% during the 3rd quarter. Atomi Financial Group Inc. now owns 1,363 shares of the medical equipment provider’s stock worth $669,000 after purchasing an additional 178 shares during the last quarter. Park Place Capital Corp lifted its position in shares of Intuitive Surgical by 5.7% during the 3rd quarter. Park Place Capital Corp now owns 1,938 shares of the medical equipment provider’s stock worth $952,000 after purchasing an additional 105 shares during the last quarter. Traveka Wealth LLC lifted its position in shares of Intuitive Surgical by 9.3% during the 3rd quarter. Traveka Wealth LLC now owns 708 shares of the medical equipment provider’s stock worth $348,000 after purchasing an additional 60 shares during the last quarter. Dynamic Advisor Solutions LLC lifted its position in shares of Intuitive Surgical by 3.1% during the 3rd quarter. Dynamic Advisor Solutions LLC now owns 10,559 shares of the medical equipment provider’s stock worth $5,187,000 after purchasing an additional 314 shares during the last quarter. Finally, Alpha Cubed Investments LLC raised its holdings in Intuitive Surgical by 4.9% in the 3rd quarter. Alpha Cubed Investments LLC now owns 99,795 shares of the medical equipment provider’s stock valued at $49,026,000 after acquiring an additional 4,657 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on ISRG shares. Stifel Nicolaus upped their price target on Intuitive Surgical from $430.00 to $475.00 and gave the company a “buy” rating in a report on Friday, July 19th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price target for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Citigroup upped their price target on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Morgan Stanley upped their price target on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. Finally, Truist Financial upped their price target on Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a report on Tuesday, July 16th. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $449.70.

Intuitive Surgical Price Performance

Shares of ISRG stock traded up $6.93 during trading hours on Tuesday, reaching $478.16. The company had a trading volume of 267,529 shares, compared to its average volume of 1,471,518. The company has a 50 day moving average of $477.10 and a 200 day moving average of $432.68. The firm has a market cap of $169.60 billion, a price-to-earnings ratio of 85.92, a P/E/G ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The company had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.18 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,655,048.26. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 53,120 shares of company stock valued at $25,528,753. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.